Patel Kinnari 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed May 22, 2025
Insider Transaction Report
Form 4
Patel Kinnari
See Remarks
Transactions
- Sale
Common Stock
2025-05-20$6.45/sh−767$4,944→ 441,927 total
Holdings
- 104,927(indirect: By LLC)
Common Stock
- 26,774(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
- [F3]The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.